Walters Group insider trades
Walters Group has filed 1 Form 4 with the SEC that we hold, all for Zentalis Pharmaceuticals, Inc. (ZNTL), as 10% owner. Across all of them we count 1 purchase worth $15.2M and 0 sales worth $0 reported on Form 4. In the last 12 months: 1 purchase ($15.2M) and 0 sales ($0). The largest single trade was a purchase of 4,335,000 shares of Zentalis Pharmaceuticals, Inc. worth $15.2M, dated 2026-08-14. The first filing on our record is dated 2026-08-19 and the latest 2026-08-19.
Zentalis Pharmaceuticals, Inc. (ZNTL)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2026-08-14 | P, purchase reported on Form 4 | 4,335,000 | $15.2M | 2026-08-19 |
Counted from the Form 4 filings this reporting owner (SEC CIK 1177523) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms